Clinical Trial Update: Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing high-dose vs standard-dose rabeprazole for treatment response in esophageal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Esophageal Disease | Phase 3 | Status: COMPLETED